| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5889015 | ORGANON LLC | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jan, 2014
(10 years ago) | |
| US6365581 | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jan, 2014
(10 years ago) | |
| US6057307 | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jan, 2014
(10 years ago) | |
|
US6057307 (Pediatric) | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jul, 2014
(9 years ago) | |
|
US5889015 (Pediatric) | ORGANON LLC | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jul, 2014
(9 years ago) | |
|
US6365581 (Pediatric) | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jul, 2014
(9 years ago) | |
| US6068832 | ORGANON LLC | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
Aug, 2017
(6 years ago) | |
Asmanex Hfa is owned by Organon Llc.
Asmanex Hfa contains Mometasone Furoate.
Asmanex Hfa has a total of 7 drug patents out of which 7 drug patents have expired.
Expired drug patents of Asmanex Hfa are:
- US5889015
- US6365581
- US6057307
- US6057307*PED
- US5889015*PED
- US6365581*PED
- US6068832
Asmanex Hfa was authorised for market use on 12 August, 2019.
Asmanex Hfa is available in aerosol, metered;inhalation dosage forms.
Asmanex Hfa can be used as treatment of asthma.
The generics of Asmanex Hfa are possible to be released after 12 February, 2023.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Strength(NS) | Aug 12, 2022 |
| Pediatric Exclusivity(PED) | Feb 12, 2023 |
Drugs and Companies using MOMETASONE FUROATE ingredient
Market Authorisation Date: 12 August, 2019
Treatment: Treatment of asthma
Dosage: AEROSOL, METERED;INHALATION
ASMANEX HFA family patents
